Non-small cell lung cancer (nsclc) Trials in Fairfax, United States
Conditions / Non-small cell lung cancer (nsclc) / Fairfax, United States
Non-small cell lung cancer (nsclc) has been the subject of sustained clinical investigation across multiple research sites.
34 total trials for this combination
Showing top 10 of 34 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04772989 | A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies | COMPLETED | PHASE1 |
| NCT07227168 | A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer | RECRUITING | PHASE1 |
| NCT05891171 | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT06710132 | Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) | RECRUITING | — |
| NCT04513925 | A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE3 |
| NCT07291037 | Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations | RECRUITING | — |
| NCT04083599 | GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT04189614 | An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT06128551 | Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors | RECRUITING | — |
| NCT03893955 | A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |